Research Article, February 2016
Preclinical study on p28 in combination with DNA damaging and anti-mitotic agents was published in Cancer Research, American Association for Cancer Research.
p28-mediated Activation of p53 in G2/M Phase of the Cell Cycle Enhances the Efficacy of DNA Damaging and Antimitotic Chemotherapy.
Cancer Res. 2016 Feb 26; 76(8): 2354-2365